HOWARD HUGHES MEDICAL INSTITUTE
Q2 2014 13F-HR Holdings
Net value change ($000)
-109,141
(-15.5%)
New positions
71
Sold out positions
86
Turnover %
8.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Bausch Health | 6,965 | 1728.3% |
| ADBE | 4,407 | NEW |
| SBUX | 4,256 | NEW |
| SYNGENTA AG | 4,114 | NEW |
| MGM | 3,320 | 101.2% |
| LVS | 2,104 | 65.1% |
| SLB | 1,397 | 20.4% |
| MA | 1,313 | 23.8% |
| QCOM | 1,191 | 12.5% |
| TSM | 1,185 | 12.5% |
Top Reduces (Value $000, Stocks/ETFs)
| SPY | -80,149 | -20.1% |
| IWM | -22,897 | -56.2% |
| PHG | -6,505 | -100.0% |
| Monsanto | -6,377 | -97.8% |
| EMC | -6,142 | -96.8% |
| TCOM | -5,042 | -100.0% |
| M | -2,965 | -100.0% |
| DIRECTV | -2,627 | -38.2% |
| TALMER BANCORP INC | -2,578 | -5.8% |
| Hanesbrands Inc. | -2,453 | -35.6% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|